Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 7/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.61 |
| ▸ | CASP1 | P29466 | 3/20 | 0.61 |
| ▸ | CASP7 | P55210 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.55 |
| ▸ | MAPT | P10636 | 5/20 | 0.55 |
| ▸ | GAA | P10253 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.55 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 5/20 | 0.50 |
| ▸ | POLB | P06746 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | THRB | P10828 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | APEX1 | P27695 | 2/20 | 0.50 |
| ▸ | CASP6 | P55212 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1373524 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TDP1HSD17B10CASP1CASP7 | |
| SCHEMBL21834461 | 0.98 | ALDH1A1 (0.59) | ALDH1A1TDP1HSD17B10CASP1CASP7 | |
| SCHEMBL27509312 | 0.86 | RAPGEF4 (0.50) | ALDH1A1TDP1HSD17B10CASP1CASP7 | |
| SCHEMBL16369640 | 0.86 | ALDH1A1 (0.62) | ALDH1A1TDP1HSD17B10CASP1CASP7 | |
| SCHEMBL8000414 | 0.86 | RAPGEF4 (0.50) | ALDH1A1TDP1HSD17B10CASP1CASP7 | |
| Water SCHEMBL28296857 | 0.85 | RAPGEF4 (0.49) | ALDH1A1TDP1HSD17B10CASP1CASP7 | |
| SCHEMBL7420462 | 0.85 | ALDH1A1 (0.61) | ALDH1A1TDP1HSD17B10CASP1CASP7 | |
| SCHEMBL3657583 | 0.84 | ALDH1A1 (0.55) | ALDH1A1TDP1HSD17B10CASP1CASP7 | |
| SCHEMBL8519995 | 0.83 | ALDH1A1 (0.53) | ALDH1A1TDP1HSD17B10CASP1CASP7 | |
| Potassium Ion SCHEMBL28557203 | 0.81 | ALDH1A1 (0.52) | ALDH1A1TDP1HSD17B10CASP1CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4445553-B2 | — | — | 2010-04-07 | — | — | JP | claimed |
| US-7632591-B2 | Branched multiblock polybenzimidazole-benzamide copolymer and method for preparing the same, electrolyte membrane and paste/gel prepared therefrom | LG CHEM, LTD. (KR) | 2009-12-15 | — | — | US | claimed |
| JP-2008512561-A | — | — | 2008-04-24 | — | — | JP | claimed |
| WO-2007055459-A1 | BRANCHED MULTIBLOCK POLYBENZIMIDAZOLE-BENZAMIDE COPOLYMER AND METHOD FOR PREPARING THE SAME, ELECTROLYTE MEMBRANE AND PASTE/GEL PREPARED THEREFROM | LG CHEM, LTD. (KR) | 2007-05-18 | — | — | WO | claimed |
| US-20070111075-A1 | Branched multiblock polybenzimidazole-benzamide copolymer and method for preparing the same, electrolyte membrane and paste/gel prepared therefrom | LG CHEM, LTD. (KR) | 2007-05-17 | — | — | US | claimed |
| EP-0572560-B1 | USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY | SHAPIRO HOWARD K (US) | 2003-01-29 | — | — | EP | claimed |
| EP-0712866-B1 | Polymer scale deposition preventive agent | SHINETSU CHEMICAL CO (JP) | 1998-07-29 | — | — | EP | claimed |
| EP-0572560-A4 | USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY. | SHAPIRO HOWARD K (US) | 1995-04-26 | — | — | EP | claimed |
| EP-0572560-A1 | USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY | SHAPIRO, Howard, K. (US) | 1993-12-08 | — | — | EP | claimed |
| WO-1992014456-A1 | USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY | SHAPIRO HOWARD K (US) | 1992-09-03 | — | — | WO | claimed |
| EP-0261079-B1 | REACTIVE DYES, THEIR PREPARATION AND THEIR USE | CIBA-GEIGY AG (CH) | 1991-10-16 | — | — | EP | claimed |
| CN-111712263-B | Maytansinoids-based drug delivery systems | 拉德克斯公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-118852324-A | Albumin binding products of auristatin E derivatives | 拉德克斯公司 | 2024-10-29 | — | — | CN | disclosed |
| US-12043593-B2 | Method for preparation of potassium 5-lodo-2-carboxybenzene sulfonate | ARXADA AG (CH) | 2024-07-23 | — | — | US | disclosed |
| US-12043593-B2 | Method for preparation of potassium 5-lodo-2-carboxybenzene sulfonate | ARXADA AG (CH) | 2024-07-23 | — | — | US | disclosed |
| EP-0036838-A2 | Azo dyestuffs, their preparation and their use | CIBA-GEIGY AG (CH) | 1981-09-30 | — | — | EP | disclosed |
| US-4283331-A | FIBER-REACTIVE DYES | CIBA-GEIGY CORPORATION (US) | 1981-08-11 | — | — | US | disclosed |
| US-4270918-A | METALLIZED TRIAZINE-FUNCTIONAL MONOAZO DYE | CIBA-GEIGY CORPORATION (US) | 1981-06-02 | — | — | US | disclosed |
| US-4138558-A | Anthraquinone compounds | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1979-02-06 | — | — | US | disclosed |
| US-4113720-A | Disperse azo dye with diaminopyrimidine coupling component | BASF AKTIENGESELLSCHAFT (DE) | 1978-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12043593-B2 | Method for preparation of potassium 5-lodo-2-carboxybenzene sulfonate | KCNK5, KCNJ2, KCNB1 | ALDH1A1 1352/4885TDP1 4164/4885HSD17B10 1163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.